This measure assesses the percentage of COPD exacerbations for members 40 years of age and older who had an acute inpatient discharge or ED encounter on or between January 1–November 30 of the measurement year and who were dispensed appropriate medications.
Two rates are reported.
1. Dispensed a systemic corticosteroid within 14 days of the event
2. Dispensed a bronchodilator within 30 days of the event
Note: The eligible population for this measure is based on acute inpatient discharges and ED visits, not on members. It is possible for the denominator to include multiple events for the same individual.
-
-
1.5 Measure Type1.7 Electronic Clinical Quality Measure (eCQM)1.8 Level Of Analysis1.9 Care Setting1.20 Testing Data Sources
-
1.14 Numerator
This measure looks at the number of patients with an acute exacerbation related to COPD who were discharged and were dispensed medications following the discharge with appropriate medications. Two rates are reported for the numerator.
Rate 1: Dispensed prescription for systemic corticosteroid (Table PCE-C) on or 14 days after the Episode Date.
Rate 2: Dispensed prescription for a bronchodilator (Table PCE-D) on or 30 days after the Episode Date.
-
1.15 Denominator
The eligible population for the measure includes all health plan members 40 years or older as of January 1 of the measurement year discharged from an inpatient setting (acute inpatient or ED) with a principal diagnosis of COPD
-
Exclusions
1) Exclude any episodes on which the patient was transferred directly to an acute or nonacute care facility for any diagnosis.
2) Exclude inpatient ED Episodes on which the patient was readmitted to an acute or nonacute care facility for any diagnosis on or seven days after discharge.
-
Most Recent Endorsement ActivityMeasure Retired and Endorsement Removed Pulmonary Endorsement Maintenance ProjectInitial EndorsementLast UpdatedRemoval Date
-
Steward Organization EmailSteward Organization Copyright
© 2012 by the National Committee for Quality Assurance
1100 13th Street, NW, Suite 1000
Washington, DC 20005
-
-
-
Risk Adjustment
-
-
-
6.1.2 Current or Planned Use(s)
-